Rekvina Laboratories
BSE: 526075
₹ 58.00▼ 2.66 (−4.39%)28 Oct, 03:29 pm IST
- P/E
- 1,558.5x
- 52-week range
- 6.75 – 65.07
- ROCE
- −333.3%
- Sector
- Pharmaceuticals & Biotechnology
- Industry
- Pharmaceuticals
- Listed on
- BSE
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Pharmaceuticals: 221 companies →Rekvina Laboratories against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)1,558.5 against a typical 34.3: pricier than most peers (1st = cheapest).219th of 220
- Share price, 3 months+129.1% against a typical −0.5%.1st of 200
Financials
Standalone figures in ₹ crore.
| ₹ Cr. | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
| Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
| Operating Profit | −0 | 0 | 0 | 0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| OPM % | — | — | — | — | — | — | — | — | −15% | −34.3% | −8.3% | −17.9% |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | −0 | 0 | 0 | 0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Tax % | 0% | — | — | — | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Profit | −0 | 0 | 0 | 0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EPS in Rs | −0.01 | 0 | 0 | 0 | −0.06 | −0.02 | −0.03 | −0.03 | −0.02 | −0.1 | −0.05 | −0.1 |
Growth and returns
Compounded yearly rates over each period.
Compounded Sales Growth
- 10 Years
- 36%
- 5 Years
- —
- 3 Years
- —
- TTM
- —
Compounded Profit Growth
- 10 Years
- —
- 5 Years
- —
- 3 Years
- —
- TTM
- −94%
Stock Price CAGR
- 10 Years
- 25%
- 5 Years
- 63%
- 3 Years
- —
- TTM
- —
Return on Equity
- 10 Years
- —
- 5 Years
- —
- 3 Years
- —
- TTM
- —
Prices are delayed and for information only. Nothing on this page is investment advice.